Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies
Clinical trial NCT00410982 · COMPLETED
Trial details
- NCT number
- NCT00410982
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2012-09-01
- Enrollment
- 145
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.